VYCERIN | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

81 results for “VYCERIN”

Trials

View all 75 →

Vytorin Reexamination Study (0653A-174)

2,089 participants · First posted Feb 18, 2010

Vascular and Metabolic Effects of Vytorin

204 participants · First posted Aug 9, 2012

Vytorin in the Treatment of Alopecia Areata

29 participants · First posted Jan 27, 2012

Drugs

Glycerin(Clear Eyes Cooling Comfort, Clear Eyes Redness Relief Reformulated Nov 2011, Fleet Mineral Oil, Genteal Tears, Glycerolyte 57, Pedia-lax Liquid, Preparation H Cream, Procalamine 3, Refresh Optive Advanced, Refresh Optive Extended Therapy, Synovisol, Tears Lubricant)

Conditions: Cold Sore, Constipation +13 more

C₃H₈O₃

Concentrated Glycerin/Fructose

Glycerin/PEG 400

News

Vantage Secures FDA Drug Master File for VYCERIN™ API Glycerin, Enhancing Pharmaceutical Formulation Options

Page 1 of 9